NCT03460795View on ClinicalTrials.gov

Safety and Efficacy Study of Co-transfering of Mesenchymal Stem Cell and Regulatory T Cells in Treating End-stage Liver Disease

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

March 1, 2025

Study Completion Date

September 1, 2025

Conditions
Liver Cirrhosis
Interventions
BIOLOGICAL

MSC and Tregs

conventional plus MSC and Tregs or placebo treatment

Trial Locations (1)

210029

Nanjing Medical University, Nanjing

Sponsors
All Listed Sponsors
lead

Nanjing Medical University

OTHER